Skip to main content
Fig. 9 | BMC Medical Genomics

Fig. 9

From: AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Fig. 9

Rating of AMLVaran’s usability (SUS) by test persons. The graphic shows the comparison of the prototype’s performance with the final version of the software. The bars indicate the percentage of users who rated the software with a SUS score corresponding to categories “excellent”, “good”, “average” or “poor”. The final version was rated with “good” or better by 62% of the participants, while only 33% of the prototype users gave this judgement. A full third of the users considered the final system to be “excellent”. For both user studies, one user rated the system as “poor”

Back to article page